Participants (N=211) in the in-prison treatment condition effect had a higher mean number of days of community buprenorphine treatment compared to the condition in which participants initiated medication after release (P=0.005).
Post-release assessments were conducted at 1, 3, 6, and 12-month following prison release. Adult pre-release prisoners who were heroin-dependent during the year prior to incarceration were eligible. Participants were recruited from two Baltimore pre-release prisons (one for men and one for women). Follow-up assessments were completed in 2014. The trial was conducted between September 2008 and July 2012. Counseling Only)×2 ×2 (Gender) factorial design. Study design was a 2 (In-Prison Treatment: Condition: Buprenorphine Treatment: vs. This study examined whether starting buprenorphine treatment prior to prison and after release from prison would be associated with better drug treatment outcomes and whether males and females responded differently to the combination of in-prison treatment and post-release service setting.
0 kommentar(er)
